Anti-Müllerian Hormone Is Not Associated with Cardiometabolic Risk Factors in Adolescent Females

PLoS ONE

Volumn 8, Issue 5, 2013, Pages

  Anderson, Emma L ^a   Fraser, Abigail ^a   McNally, William ^b   Sattar, Naveed ^c   Lashen, Hany ^d   Fleming, Richard ^b   Nelson, Scott M ^b   Lawlor, Debbie A ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

^c UNIVERSITY OF GLASGOW   (United Kingdom)

^d UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MUELLERIAN INHIBITING FACTOR; SEX HORMONE BINDING GLOBULIN; TRIACYLGLYCEROL;

ADOLESCENT; ADOLESCENT HEALTH; ARTICLE; BIRTH WEIGHT; BODY MASS; CARDIOMETABOLIC RISK; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; ETHNICITY; FEMALE; GENDER BIAS; GESTATIONAL AGE; HORMONAL CONTRACEPTION; HUMAN; HUMAN EXPERIMENT; INSULIN BLOOD LEVEL; LONGITUDINAL STUDY; MENARCHE; NORMAL HUMAN; OBESITY; PHYSICAL ACTIVITY; PROTEIN BLOOD LEVEL; PUBERTY; RISK FACTOR; SMOKING; SOCIAL STATUS; TRIACYLGLYCEROL BLOOD LEVEL; BLOOD; CARDIOVASCULAR DISEASES; CHILD; YOUNG ADULT;

ADOLESCENT; ANTI-MULLERIAN HORMONE; CARDIOVASCULAR DISEASES; CHILD; FEMALE; HUMANS; LONGITUDINAL STUDIES; RISK FACTORS; YOUNG ADULT;

EID: 84878529206     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0064510     Document Type: Article

References (59)

1. Hansen KR, Hodnett GM, Knowlton N, Craig LB, (2011) Correlation of ovarian reserve tests with histologically determined primordial follicle number. Fertility and Sterility 95: 170-175.
2. Fleming R, Kelsey TW, Anderson RA, Wallace WH, Nelson SM, (2012) Interpreting human follicular recruitment and antimullerian hormone concentrations throughout life. Fertility and Sterility 98: 1097-1102.
3. van Rooij IA, Tonkelaar I, Broekmans FJ, Looman CW, Scheffer GJ, et al. (2004) Anti-mullerian hormone is a promising predictor for the occurrence of the menopausal transition. Menopause 11: 601-606.
4. Hagen CP, Aksglaede L, Sørensen K, Main KM, Boas M, et al. (2010) Serum Levels of Anti-Mullerian Hormone as a Marker of Ovarian Function in 926 Healthy Females from Birth to Adulthood and in 172 Turner Syndrome Patients. Journal of Clinical Endocrinology & Metabolism 95: 5003-5010.
5. Kelsey T, Wright P, Nelson SM, Anderson RA, Wallace WHB, (2012) Data Aggregation and Analysis for Assessment of Ovarian Reserve. Mol Cell Endocrinol 18: 79-87.
6. Aksglaede L, Sorensen K, Boas M, Mouritsen A, Hagen CP, et al. (2010) Changes in anti-Mullerian hormone (AMH) throughout the life span: a population-based study of 1027 healthy males from birth (cord blood) to the age of 69 years. J Clin Endocrinol Metab 95: 5357-5364.
7. Atsma F, Bartelink ML, Grobbee DE, van der Schouw YT (2006) Postmenopausal status and early menopause as independent risk factors for cardiovascular disease: a meta-analysis. Menopause 13:.
8. van der Schouw YT, van der Graaf Y, (1996) Age at menopause as a risk factor for cardiovascular mortality. Lancet 347: 714.
9. Hu FB, Goldstein F, Hennekens CH, (1999) AGe at natural menopause and risk of cardiovascular disease. Arch Intern Med 159: 1061-1066.
10. Berenson GS, Srinivasan SR, Bao W, Newman WP, Tracy RE, et al. (1998) Association between Multiple Cardiovascular Risk Factors and Atherosclerosis in Children and Young Adults. New England Journal of Medicine 338: 1650-1656.
11. Chu MC, Rath KM, Huie J, Taylor HS, (2003) Elevated basal FSH in normal cycling women is associated with unfavourable lipid levels and increased cardiovascular risk. Human Reproduction 18: 1570-1573.
12. Bayrak A, Terbell H, Urwitz-Lane R, Mor E, Stanczyk FZ, et al. (2007) Acute effects of metformin therapy include improvement of insulin resistance and ovarian morphology. Fertil Steril 87: 870-875.
13. Buyuk E, Seifer DB, Illions E, Grazi RV, Lieman H, (2011) Elevated body mass index is associated with lower serum anti-mullerian hormone levels in infertile women with diminished ovarian reserve but not with normal ovarian reserve. Fertil Steril 95: 2364-2368.
14. Chen MJ, Yang WS, Chen CL, Wu MY, Yang YS, et al. (2008) The relationship between anti-Mullerian hormone, androgen and insulin resistance on the number of antral follicles in women with polycystic ovary syndrome. Hum Reprod 23: 952-957.
15. Freeman EW, Gracia CR, Sammel MD, Lin H, Lim LC-L, et al. (2007) Association of anti-mullerian hormone levels with obesity in late reproductive-age women. Fertility and Sterility 87: 101-106.
16. La Marca A, Orvieto R, Giulini S, Jasonni VM, Volpe A, et al. (2004) Mullerian-inhibiting substance in women with polycystic ovary syndrome: relationship with hormonal and metabolic characteristics. Fertil Steril 82: 970-972.
17. La Marca A, Spada E, Grisendi V, Argento C, Papaleo E, et al. (2012) Normal serum anti-Mullerian hormone levels in the general female population and the relationship with reproductive history. European Journal of Obstetrics & Gynecology and Reproductive Biology 163: 180-184.
18. Piouka A, Farmakiotis D, Katsikis I, Macut D, Gerou S, et al. (2009) Anti-Mullerian hormone levels reflect severity of PCOS but are negatively influenced by obesity: relationship with increased luteinizing hormone levels. American Journal of Physiology- Endocrinology And Metabolism 296: E238-E243.
19. Sir-Petermann T, Codner E, Maliqueo M, Echiburu B, Hitschfeld C, et al. (2006) Increased anti-Mullerian hormone serum concentrations in prepubertal daughters of women with polycystic ovary syndrome. J Clin Endocrinol Metab 91: 3105-3109.
20. Skalba P, Cygal A, Pawel M, Dabkowska-Huc A, Sikora J, et al. (2011) Is the plasma anti-Mullerian hormone (AMH) level associated with body weight and metabolic, and hormonal disturbances in women with and without polycystic ovary syndrome? European Journal of Obstetrics & Gynecology and Reproductive Biology 158: 254-259.
21. Steiner AZ, Stanczyk FZ, Patel S, Edelman A, (2010) Antimullerian hormone and obesity: insights in oral contraceptive users. Contraception 81: 245-248.
22. Thomson RL, Buckley JD, Moran LJ, Noakes M, Clifton PM, et al. (2009) The effect of weight loss on anti-Mullerian hormone levels in overweight and obese women with polycystic ovary syndrome and reproductive impairment. Human Reproduction 24: 1976-1981.
23. Woo HY, Kim KH, Rhee EJ, Park H, Lee MK, (2012) Differences of the association of anti-Mullerian hormone with clinical or biochemical characteristics between women with and without polycystic ovary syndrome. Endocrine Journal 59: 781-790.
24. Appt SE, Chen H, Clarkson TB, Kaplan JR (2012) Premenopausal antimullerian hormone concentration is associated with subsequent atherosclerosis. Menopause [Epub ahead of print]:.
25. Nardo LG, Yates AP, Roberts SA, Pemberton P, Laing I, (2009) The relationships between AMH, androgens, insulin resistance and basal ovarian follicular status in non-obese subfertile women with and without polycystic ovary syndrome. Hum Reprod 24: 2917-2923.
26. Villarroel C, Merino PM, López P, Eyzaguirre FC, Van Velzen A, et al. (2011) Polycystic ovarian morphology in adolescents with regular menstrual cycles is associated with elevated anti-Mullerian hormone. Human Reproduction 26: 2861-2868.
27. Park HT, Cho GJ, Ahn KH, Shin JH, Kim YT, e al, (2010) Association of insulin resistance with anti-Mullerian hormone levels in women without polycystic ovary syndrome (PCOS). Clin Endocrinol (Oxf) 72: 26-31.
28. Nelson SM, Stewart F, Fleming R, Freeman DJ, (2010) Longitudinal assessment of antimullerian hormone during pregnancy-relationship with maternal adiposity, insulin, and adiponectin. Fertil Steril 93: 1356-1358.
29. Freour T, Masson D, Mirallie S, Jean M, Bach K, et al. (2008) Active smoking compromises IVF outcome and affects ovarian reserve. Reprod Biomed Online 16: 96-102.
30. Kerkhof GF, Leunissen RWJ, Willemsen RH, de Jong FH, Visser JA, et al. (2010) Influence of preterm birth and small birth size on serum anti-Mullerian hormone levels in young adult women. European Journal of Endocrinology 163: 937-944.
31. Hehenkamp WJK, Volkers NA, Broekmans FJM, de Jong FH, Themmen APN, et al. (2007) Loss of ovarian reserve after uterine artery embolization: a randomized comparison with hysterectomy. Human Reproduction 22: 1996-2005.
32. Hagen CP, Aksglaede L, Sorensen K, Mouritsen A, Andersson AM, et al. (2012) Individual serum levels of anti-Mullerian hormone in healthy girls persist through childhood and adolescence: a longitudinal cohort study. Human Reproduction 27: 861-866.
33. Kelsey TW, Wright P, Nelson SM, Anderson RA, Wallace WH, (2011) A Validated Model of Serum Anti-Mullerian Hormone from Conception to Menopause. PLoS ONE 6: e22024.
34. Strong JP, Malcom GT, McMahan CA, Tracy RE, Newman WP III, et al. (1999) Prevalence and extent of atherosclerosis in adolescents and young adults: Implications for prevention from the pathobiological determinants of atherosclerosis in youth study. JAMA 281: 727-735.
35. McCarron P, Smith GD, Okasha M, McEwen J, (2000) Blood pressure in young adulthood and mortality from cardiovascular disease. The Lancet 355: 1430-1431.
36. Juonala M, Magnussen CG, Venn A, Dwyer T, Burns TL, et al. (2010) Influence of Age on Associations Between Childhood Risk Factors and Carotid Intima-Media Thickness in Adulthood: The Cardiovascular Risk in Young Finns Study, the Childhood Determinants of Adult Health Study, the Bogalusa Heart Study, and the Muscatine Study for the International Childhood Cardiovascular Cohort (i3C) Consortium. Circulation 122: 2514-2520.
37. Raitakari OT JM, (2003) Cardiovascular risk factors in childhood and carotid artery intima-media thickness in adulthood: The cardiovascular risk in young finns study. JAMA 290: 2277-2283.
38. Boyd A, Golding J, Macleod J, Lawlor DA, Fraser A, et al. (2012) Cohort Profile: The 'Children of the 90s'- the index offspring of the Avon Longitudinal Study of Parents and Children. International Journal of Epidemiology.
39. Fraser A, Macdonald-Wallis C, Tilling K, Boyd A, Golding J, et al. (2012) Cohort Profile: The Avon Longitudinal Study of Parents and Children: ALSPAC mothers cohort. International Journal of Epidemiology.
40. Wallace AM, Faye SA, Fleming R, Nelson SM, (2011) A multicentre evaluation of the new Beckman Coulter anti-Mullerian hormone immunoassay (AMH Gen II). Annals of Clinical Biochemistry 48: 370-373.
41. Friedewald WT, Levy RI, Fredrickson DS, (1972) Estimation of the Concentration of Low-Density Lipoprotein Cholesterol in Plasma, Without Use of the Preparative Ultracentrifuge. Clin Chem 18: 499-502.
42. Gungor N, Saad R, Janosky J, Arslanian S, (2004) Validation of surrogate estimates of insulin sensitivity and insulin secretion in children and adolescents. J Pediatr 144: 47-55.
43. Schwartz B, Jacobs DR Jr, Moran A, Steinberger J, Hong CP, et al. (2008) Measurement of insulin sensitivity in children: comparison between the euglycemic-hyperinsulinemic clamp and surrogate measures. Diabetes Care 31: 783-788.
44. Levy-Marchal C, Arslanian S, Cutfield W, Sinaiko A, Druet C, et al. (2010) Insulin resistance in children: consensus, perspective, and future directions. J Clin Endocrinol Metab 95: 5189-5198.
45. Marshall WA, Tanner JM, (1969) Variations in pattern of pubertal changes in girls. Arch Dis Child 44: 291-303.
46. Morris N, Udry JR, (1980) Validation of a self-administered instrument to assess stage of adolescent development. J Youth Adolescence 9: 271-280.
47. Mattocks C, Ness A, Leary S, Tilling K, Blair SN, et al. (2008) Use of accelerometers in a large field-based study of children: protocols, design issues, and effects on precision. J Phys Act Health 5Suppl 1: S98-111.
48. Riddoch CJ, Mattocks C, Deere K, Saunders J, Kirkby J, et al. (2007) Objective measurement of levels and patterns of physical activity. Archives of Disease in Childhood 92: 963-969.
49. Codner E, Iniguez G, Hernandez IM, Lopez P, Rhumie HK, et al. (2011) Elevated anti-Mullerian hormone (AMH) and inhibin B levels in prepubertal girls with type 1 diabetes mellitus. Clin Endocrinol (Oxf) 74: 73-78.
50. Palomba S, Falbo A, Zullo F, Orio F, (2009) Evidence-Based and Potential Benefits of Metformin in the Polycystic Ovary Syndrome: A Comprehensive Review. Endocrine Reviews 30: 1-50.
51. Lin YH, Chiu WC, Wu CH, Tzeng CR, Hsu CS, et al. (2011) Antimullerian hormone and polycystic ovary syndrome. Fertil Steril 96: 230-235.
52. Johnstone EB, Rosen MP, Neril R, Trevithick D, Sternfeld B, et al. (2010) The polycystic ovary post-rotterdam: a common, age-dependent finding in ovulatory women without metabolic significance. J Clin Endocrinol Metab 95: 4965-4972.
53. Lawlor DA, Benfield L, Logue J, Tilling K, Howe LD, et al. (2010) Association between general and central adiposity in childhood, and change in these, with cardiovascular risk factors in adolescence: prospective cohort study. BMJ 341:.
54. Rockett JC, Lynch CD, Buck GM, (2004) Biomarkers for assessing reproductive development and health: Part 1-Pubertal development. Environ Health Perspect 112: 105-112.
55. Hergenroeder AC, Hill RB, Wong WW, Sangi-Haghpeykar H, Taylor W, (1999) Validity of self-assessment of pubertal maturation in African American and European American adolescents. J Adolesc Health 24: 201-205.
56. Blanck HM, Marcus M, Tolbert PE, Rubin C, Henderson AK, et al. (2000) Age at menarche and tanner stage in girls exposed in utero and postnatally to polybrominated biphenyl. Epidemiology 11: 641-647.
57. Gladen BC, Ragan NB, Rogan WJ, (2000) Pubertal growth and development and prenatal and lactational exposure to polychlorinated biphenyls and dichlorodiphenyl dichloroethene. J Pediatr 136: 490-496.
58. Hickey M, Doherty DA, Atkinson H, Sloboda DM, Franks S, et al. (2011) Clinical, ultrasound and biochemical features of polycystic ovary syndrome in adolescents: implications for diagnosis. Human Reproduction 26: 1469-1477.
59. Hart R, Doherty DA, Norman RJ, Franks S, Dickinson JE, et al. (2010) Serum antimullerian hormone (AMH) levels are elevated in adolescent girls with polycystic ovaries and the polycystic ovarian syndrome (PCOS). Fertility and Sterility 94: 1118-1121.